Review



raav vectors  (Bio-Rad)


Bioz Verified Symbol Bio-Rad is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 96

    Structured Review

    Bio-Rad raav vectors
    Bio-conjugation of rAAV6 with mannose allowed high-level nanoblade-mediated knockin into CD34 + cells and reduced cell death (A and B) K562 cells were transduced at an MOI of 50,000 (vg/cell) with the unmodified rAAV2 and rAAV6 vectors (Ctrl) or with rAAV2 and rAAV6 bio-conjugated with mannose sugars at their lysine residues (K3E5 or K3E6) or tyrosine residues (Y3E5) in the presence of nanoblades. At day 3 and 6 post incubation with <t>rAAV</t> <t>vectors</t> and nanoblades, the % of knockin was determined by % of (A) GFP-expressing K562 cells and their survival using DAPI staining (B) analyzed by FACS; mean (SD); n = 3; three biological repeats; multiple Student’s t test, Tukey’s multiple comparisons test; ∗∗∗∗ p < 0.001. (C and D) CD34 + cells were pre-stimulated with cytokines overnight and were then transduced at an MOI of 50,000 (vg/cell) with the unmodified rAAV2 and rAAV6 vectors (Ctrl) or with rAAV2 and rAAV6 bio-conjugated with mannose sugars at their lysine residues (K3E5 or K3E6) or tyrosine residues (Y3E5; see also <xref ref-type=Table S1 ) in the presence of nanoblades. At day 3 and 6 post transduction, the % of GFP-positive CD34 + cells (% knockin; C) and their survival (D) were determined using FACS analysis; mean (SD); n = 3; three biological repeats for which three independent CD34 + cell donors were used; multiple Student’s t test, Tukey’s multiple comparisons test; ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001. (E) Representative FACS analysis for the data in (C) showing gene knockin by analysis of GFP expression in the CD34 + cells at day 6. " width="250" height="auto" />
    Raav Vectors, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 96/100, based on 4363 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/raav vectors/product/Bio-Rad
    Average 96 stars, based on 4363 article reviews
    raav vectors - by Bioz Stars, 2026-03
    96/100 stars

    Images

    1) Product Images from "Ligand-modified rAAV6 vectors with nanoblades allow high-level gene knockin in HSPCs without compromising cell survival"

    Article Title: Ligand-modified rAAV6 vectors with nanoblades allow high-level gene knockin in HSPCs without compromising cell survival

    Journal: Molecular Therapy. Nucleic Acids

    doi: 10.1016/j.omtn.2025.102495

    Bio-conjugation of rAAV6 with mannose allowed high-level nanoblade-mediated knockin into CD34 + cells and reduced cell death (A and B) K562 cells were transduced at an MOI of 50,000 (vg/cell) with the unmodified rAAV2 and rAAV6 vectors (Ctrl) or with rAAV2 and rAAV6 bio-conjugated with mannose sugars at their lysine residues (K3E5 or K3E6) or tyrosine residues (Y3E5) in the presence of nanoblades. At day 3 and 6 post incubation with rAAV vectors and nanoblades, the % of knockin was determined by % of (A) GFP-expressing K562 cells and their survival using DAPI staining (B) analyzed by FACS; mean (SD); n = 3; three biological repeats; multiple Student’s t test, Tukey’s multiple comparisons test; ∗∗∗∗ p < 0.001. (C and D) CD34 + cells were pre-stimulated with cytokines overnight and were then transduced at an MOI of 50,000 (vg/cell) with the unmodified rAAV2 and rAAV6 vectors (Ctrl) or with rAAV2 and rAAV6 bio-conjugated with mannose sugars at their lysine residues (K3E5 or K3E6) or tyrosine residues (Y3E5; see also <xref ref-type=Table S1 ) in the presence of nanoblades. At day 3 and 6 post transduction, the % of GFP-positive CD34 + cells (% knockin; C) and their survival (D) were determined using FACS analysis; mean (SD); n = 3; three biological repeats for which three independent CD34 + cell donors were used; multiple Student’s t test, Tukey’s multiple comparisons test; ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001. (E) Representative FACS analysis for the data in (C) showing gene knockin by analysis of GFP expression in the CD34 + cells at day 6. " title="... At day 3 and 6 post incubation with rAAV vectors and nanoblades, the % of knockin was ..." property="contentUrl" width="100%" height="100%"/>
    Figure Legend Snippet: Bio-conjugation of rAAV6 with mannose allowed high-level nanoblade-mediated knockin into CD34 + cells and reduced cell death (A and B) K562 cells were transduced at an MOI of 50,000 (vg/cell) with the unmodified rAAV2 and rAAV6 vectors (Ctrl) or with rAAV2 and rAAV6 bio-conjugated with mannose sugars at their lysine residues (K3E5 or K3E6) or tyrosine residues (Y3E5) in the presence of nanoblades. At day 3 and 6 post incubation with rAAV vectors and nanoblades, the % of knockin was determined by % of (A) GFP-expressing K562 cells and their survival using DAPI staining (B) analyzed by FACS; mean (SD); n = 3; three biological repeats; multiple Student’s t test, Tukey’s multiple comparisons test; ∗∗∗∗ p < 0.001. (C and D) CD34 + cells were pre-stimulated with cytokines overnight and were then transduced at an MOI of 50,000 (vg/cell) with the unmodified rAAV2 and rAAV6 vectors (Ctrl) or with rAAV2 and rAAV6 bio-conjugated with mannose sugars at their lysine residues (K3E5 or K3E6) or tyrosine residues (Y3E5; see also Table S1 ) in the presence of nanoblades. At day 3 and 6 post transduction, the % of GFP-positive CD34 + cells (% knockin; C) and their survival (D) were determined using FACS analysis; mean (SD); n = 3; three biological repeats for which three independent CD34 + cell donors were used; multiple Student’s t test, Tukey’s multiple comparisons test; ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001. (E) Representative FACS analysis for the data in (C) showing gene knockin by analysis of GFP expression in the CD34 + cells at day 6.

    Techniques Used: Conjugation Assay, Knock-In, Incubation, Expressing, Staining, Transduction



    Similar Products

    95
    ATCC recombinant adeno associated virus raav vectors
    Recombinant Adeno Associated Virus Raav Vectors, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/recombinant adeno associated virus raav vectors/product/ATCC
    Average 95 stars, based on 1 article reviews
    recombinant adeno associated virus raav vectors - by Bioz Stars, 2026-03
    95/100 stars
      Buy from Supplier

    90
    Shanghai Biotechnology Co Ltd recombinant adeno-associated virus (raav) vectors encoding egfp
    Distribution of enhanced green fluorescent protein (EGFP) and the knockdown efficiency <t>of</t> <t>rAAV-CR</t> <t>shRNA</t> on PFC CR expression in mice. ( A ) Viral genome maps for viruses designed to express CR and EGFP. ( B ) EGFP signals confirmed by immunofluorescence in the PFC around 21 days post injection. ( C ) The boxed area is exhibited in ( B ) at a higher magnification. ( D - E ) Three weeks after the injection of rAAV vectors, CR protein expression in mice with rAAV-CR shRNA intra-PFC injection ( n = 6). ( F ) Representative images depicting CR-positive cells in sections obtained from the rAAV-EGFP- and rAAV-CR shRNA-treated animals. Upper row: Immunohistochemical detection of CR-containing cells in 10 objective lens. Bottom row: regions of PFC sketched by the black boxes in the upper row were visualized using 40 objective lens. Some CR-immunogenic neurons have been identified by arrows. ( G ) Significant expression is detected of CR interneurons in mice exposed with rAAV-CR shRNA injection ( n = 5 each). ** p < 0.01, *** p < 0.001, compared with rAAV-EGFP-exposed animals. Student’s t -test. Data are presented as means ± SEM
    Recombinant Adeno Associated Virus (Raav) Vectors Encoding Egfp, supplied by Shanghai Biotechnology Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/recombinant adeno-associated virus (raav) vectors encoding egfp/product/Shanghai Biotechnology Co Ltd
    Average 90 stars, based on 1 article reviews
    recombinant adeno-associated virus (raav) vectors encoding egfp - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    90
    Shanghai Biotechnology Co Ltd recombinant adeno-associated virus (raav) vectors expressing cr shrna
    Distribution of enhanced green fluorescent protein (EGFP) and the knockdown efficiency <t>of</t> <t>rAAV-CR</t> <t>shRNA</t> on PFC CR expression in mice. ( A ) Viral genome maps for viruses designed to express CR and EGFP. ( B ) EGFP signals confirmed by immunofluorescence in the PFC around 21 days post injection. ( C ) The boxed area is exhibited in ( B ) at a higher magnification. ( D - E ) Three weeks after the injection of rAAV vectors, CR protein expression in mice with rAAV-CR shRNA intra-PFC injection ( n = 6). ( F ) Representative images depicting CR-positive cells in sections obtained from the rAAV-EGFP- and rAAV-CR shRNA-treated animals. Upper row: Immunohistochemical detection of CR-containing cells in 10 objective lens. Bottom row: regions of PFC sketched by the black boxes in the upper row were visualized using 40 objective lens. Some CR-immunogenic neurons have been identified by arrows. ( G ) Significant expression is detected of CR interneurons in mice exposed with rAAV-CR shRNA injection ( n = 5 each). ** p < 0.01, *** p < 0.001, compared with rAAV-EGFP-exposed animals. Student’s t -test. Data are presented as means ± SEM
    Recombinant Adeno Associated Virus (Raav) Vectors Expressing Cr Shrna, supplied by Shanghai Biotechnology Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/recombinant adeno-associated virus (raav) vectors expressing cr shrna/product/Shanghai Biotechnology Co Ltd
    Average 90 stars, based on 1 article reviews
    recombinant adeno-associated virus (raav) vectors expressing cr shrna - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    90
    Inserm Transfert raav vectors
    Distribution of enhanced green fluorescent protein (EGFP) and the knockdown efficiency <t>of</t> <t>rAAV-CR</t> <t>shRNA</t> on PFC CR expression in mice. ( A ) Viral genome maps for viruses designed to express CR and EGFP. ( B ) EGFP signals confirmed by immunofluorescence in the PFC around 21 days post injection. ( C ) The boxed area is exhibited in ( B ) at a higher magnification. ( D - E ) Three weeks after the injection of rAAV vectors, CR protein expression in mice with rAAV-CR shRNA intra-PFC injection ( n = 6). ( F ) Representative images depicting CR-positive cells in sections obtained from the rAAV-EGFP- and rAAV-CR shRNA-treated animals. Upper row: Immunohistochemical detection of CR-containing cells in 10 objective lens. Bottom row: regions of PFC sketched by the black boxes in the upper row were visualized using 40 objective lens. Some CR-immunogenic neurons have been identified by arrows. ( G ) Significant expression is detected of CR interneurons in mice exposed with rAAV-CR shRNA injection ( n = 5 each). ** p < 0.01, *** p < 0.001, compared with rAAV-EGFP-exposed animals. Student’s t -test. Data are presented as means ± SEM
    Raav Vectors, supplied by Inserm Transfert, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/raav vectors/product/Inserm Transfert
    Average 90 stars, based on 1 article reviews
    raav vectors - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    90
    Jackson Laboratory raav vectors
    Distribution of enhanced green fluorescent protein (EGFP) and the knockdown efficiency <t>of</t> <t>rAAV-CR</t> <t>shRNA</t> on PFC CR expression in mice. ( A ) Viral genome maps for viruses designed to express CR and EGFP. ( B ) EGFP signals confirmed by immunofluorescence in the PFC around 21 days post injection. ( C ) The boxed area is exhibited in ( B ) at a higher magnification. ( D - E ) Three weeks after the injection of rAAV vectors, CR protein expression in mice with rAAV-CR shRNA intra-PFC injection ( n = 6). ( F ) Representative images depicting CR-positive cells in sections obtained from the rAAV-EGFP- and rAAV-CR shRNA-treated animals. Upper row: Immunohistochemical detection of CR-containing cells in 10 objective lens. Bottom row: regions of PFC sketched by the black boxes in the upper row were visualized using 40 objective lens. Some CR-immunogenic neurons have been identified by arrows. ( G ) Significant expression is detected of CR interneurons in mice exposed with rAAV-CR shRNA injection ( n = 5 each). ** p < 0.01, *** p < 0.001, compared with rAAV-EGFP-exposed animals. Student’s t -test. Data are presented as means ± SEM
    Raav Vectors, supplied by Jackson Laboratory, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/raav vectors/product/Jackson Laboratory
    Average 90 stars, based on 1 article reviews
    raav vectors - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier



    93
    Addgene inc vector raav hsyn1 syfp2 10aa h2b wpre3 bghpa
    Bio-conjugation of rAAV6 with mannose allowed high-level nanoblade-mediated knockin into CD34 + cells and reduced cell death (A and B) K562 cells were transduced at an MOI of 50,000 (vg/cell) with the unmodified rAAV2 and rAAV6 vectors (Ctrl) or with rAAV2 and rAAV6 bio-conjugated with mannose sugars at their lysine residues (K3E5 or K3E6) or tyrosine residues (Y3E5) in the presence of nanoblades. At day 3 and 6 post incubation with <t>rAAV</t> <t>vectors</t> and nanoblades, the % of knockin was determined by % of (A) GFP-expressing K562 cells and their survival using DAPI staining (B) analyzed by FACS; mean (SD); n = 3; three biological repeats; multiple Student’s t test, Tukey’s multiple comparisons test; ∗∗∗∗ p < 0.001. (C and D) CD34 + cells were pre-stimulated with cytokines overnight and were then transduced at an MOI of 50,000 (vg/cell) with the unmodified rAAV2 and rAAV6 vectors (Ctrl) or with rAAV2 and rAAV6 bio-conjugated with mannose sugars at their lysine residues (K3E5 or K3E6) or tyrosine residues (Y3E5; see also <xref ref-type=Table S1 ) in the presence of nanoblades. At day 3 and 6 post transduction, the % of GFP-positive CD34 + cells (% knockin; C) and their survival (D) were determined using FACS analysis; mean (SD); n = 3; three biological repeats for which three independent CD34 + cell donors were used; multiple Student’s t test, Tukey’s multiple comparisons test; ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001. (E) Representative FACS analysis for the data in (C) showing gene knockin by analysis of GFP expression in the CD34 + cells at day 6. " width="250" height="auto" />
    Vector Raav Hsyn1 Syfp2 10aa H2b Wpre3 Bghpa, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/vector raav hsyn1 syfp2 10aa h2b wpre3 bghpa/product/Addgene inc
    Average 93 stars, based on 1 article reviews
    vector raav hsyn1 syfp2 10aa h2b wpre3 bghpa - by Bioz Stars, 2026-03
    93/100 stars
      Buy from Supplier

    Image Search Results


    Distribution of enhanced green fluorescent protein (EGFP) and the knockdown efficiency of rAAV-CR shRNA on PFC CR expression in mice. ( A ) Viral genome maps for viruses designed to express CR and EGFP. ( B ) EGFP signals confirmed by immunofluorescence in the PFC around 21 days post injection. ( C ) The boxed area is exhibited in ( B ) at a higher magnification. ( D - E ) Three weeks after the injection of rAAV vectors, CR protein expression in mice with rAAV-CR shRNA intra-PFC injection ( n = 6). ( F ) Representative images depicting CR-positive cells in sections obtained from the rAAV-EGFP- and rAAV-CR shRNA-treated animals. Upper row: Immunohistochemical detection of CR-containing cells in 10 objective lens. Bottom row: regions of PFC sketched by the black boxes in the upper row were visualized using 40 objective lens. Some CR-immunogenic neurons have been identified by arrows. ( G ) Significant expression is detected of CR interneurons in mice exposed with rAAV-CR shRNA injection ( n = 5 each). ** p < 0.01, *** p < 0.001, compared with rAAV-EGFP-exposed animals. Student’s t -test. Data are presented as means ± SEM

    Journal: Molecular Brain

    Article Title: Deficiency of calretinin in prefrontal cortex causes behavioral deficits relevant to autism spectrum disorder in mice

    doi: 10.1186/s13041-025-01233-7

    Figure Lengend Snippet: Distribution of enhanced green fluorescent protein (EGFP) and the knockdown efficiency of rAAV-CR shRNA on PFC CR expression in mice. ( A ) Viral genome maps for viruses designed to express CR and EGFP. ( B ) EGFP signals confirmed by immunofluorescence in the PFC around 21 days post injection. ( C ) The boxed area is exhibited in ( B ) at a higher magnification. ( D - E ) Three weeks after the injection of rAAV vectors, CR protein expression in mice with rAAV-CR shRNA intra-PFC injection ( n = 6). ( F ) Representative images depicting CR-positive cells in sections obtained from the rAAV-EGFP- and rAAV-CR shRNA-treated animals. Upper row: Immunohistochemical detection of CR-containing cells in 10 objective lens. Bottom row: regions of PFC sketched by the black boxes in the upper row were visualized using 40 objective lens. Some CR-immunogenic neurons have been identified by arrows. ( G ) Significant expression is detected of CR interneurons in mice exposed with rAAV-CR shRNA injection ( n = 5 each). ** p < 0.01, *** p < 0.001, compared with rAAV-EGFP-exposed animals. Student’s t -test. Data are presented as means ± SEM

    Article Snippet: The recombinant adeno-associated virus (rAAV) vectors expressing CR shRNA (rAAV-GAD67-CR-shRNA-CMV-EGFP-WPRE-hGH-ITR, 5.54 × 10 12 vg/ml) were supplied by Shanghai Biotechnology Co., Ltd.

    Techniques: Knockdown, shRNA, Expressing, Immunofluorescence, Injection, Immunohistochemical staining

    Deficiency of CR resulted in social impairments in the three-chamber test. ( A ) In three-chamber social interaction test, rAAV-EGFP-injected mice spent obviously more time in the chambers of the unfamiliar animal relative to the novel object. In contrast, rAAV-CR shRNA treatment was associated with these animals having spent equal amounts of time in the chamber containing the novel mouse and the unfamiliar object. ( B ) The rAAV-EGFP-exposed mice spent more time sniffing the novel mouse as compared to the unfamiliar object. Mice with rAAV-CR shRNA injection spent similar time sniffing with the novel mouse and the unfamiliar object. ( C ) The rAAV-CR shRNA group had an evidently lower social preference index than the control animals. n = 10. *** p < 0.001, ### p < 0.001 for novel mouse vs. novel object. ^^^ p < 0.001, compared with rAAV-EGFP-treated group. “ns” indicating no statistical significance. One-way ANOVA with Tukey’s post hoc test. Student’s t -test. Data are means ± SEM. ( D ) In test for social novelty preferences, mice with rAAV-EGFP injection spent more time exploring the compartment containing the stranger mouse compared with familiar controls. In contrast, no considerable difference in the time spent exploring the compartment containing the novel mouse compared with the time spent exploring the familiar animal in rAAV-CR shRNA-operated mice. ( E ) The rAAV-EGFP-injected mice spent significantly more time sniffing and engaging with the novel mouse in comparison with the familiar mouse. In contrast, rAAV-CR shRNA-treated mice spent equal amounts of time sniffing the novel mouse and the familiar animal. ( F ) The rAAV-CR shRNA-administered mice had significantly a lower discrimination index than the control animals. n = 10. &&& p < 0.001, $$$ p < 0.001 for novel mouse vs. familiar mouse. ^^^ p < 0.001, compared with rAAV-EGFP-treated mice. “ns” indicating no statistical significance. One-way ANOVA with Tukey’s post hoc test. Student’s t -test. Data are presented as means ± SEM

    Journal: Molecular Brain

    Article Title: Deficiency of calretinin in prefrontal cortex causes behavioral deficits relevant to autism spectrum disorder in mice

    doi: 10.1186/s13041-025-01233-7

    Figure Lengend Snippet: Deficiency of CR resulted in social impairments in the three-chamber test. ( A ) In three-chamber social interaction test, rAAV-EGFP-injected mice spent obviously more time in the chambers of the unfamiliar animal relative to the novel object. In contrast, rAAV-CR shRNA treatment was associated with these animals having spent equal amounts of time in the chamber containing the novel mouse and the unfamiliar object. ( B ) The rAAV-EGFP-exposed mice spent more time sniffing the novel mouse as compared to the unfamiliar object. Mice with rAAV-CR shRNA injection spent similar time sniffing with the novel mouse and the unfamiliar object. ( C ) The rAAV-CR shRNA group had an evidently lower social preference index than the control animals. n = 10. *** p < 0.001, ### p < 0.001 for novel mouse vs. novel object. ^^^ p < 0.001, compared with rAAV-EGFP-treated group. “ns” indicating no statistical significance. One-way ANOVA with Tukey’s post hoc test. Student’s t -test. Data are means ± SEM. ( D ) In test for social novelty preferences, mice with rAAV-EGFP injection spent more time exploring the compartment containing the stranger mouse compared with familiar controls. In contrast, no considerable difference in the time spent exploring the compartment containing the novel mouse compared with the time spent exploring the familiar animal in rAAV-CR shRNA-operated mice. ( E ) The rAAV-EGFP-injected mice spent significantly more time sniffing and engaging with the novel mouse in comparison with the familiar mouse. In contrast, rAAV-CR shRNA-treated mice spent equal amounts of time sniffing the novel mouse and the familiar animal. ( F ) The rAAV-CR shRNA-administered mice had significantly a lower discrimination index than the control animals. n = 10. &&& p < 0.001, $$$ p < 0.001 for novel mouse vs. familiar mouse. ^^^ p < 0.001, compared with rAAV-EGFP-treated mice. “ns” indicating no statistical significance. One-way ANOVA with Tukey’s post hoc test. Student’s t -test. Data are presented as means ± SEM

    Article Snippet: The recombinant adeno-associated virus (rAAV) vectors expressing CR shRNA (rAAV-GAD67-CR-shRNA-CMV-EGFP-WPRE-hGH-ITR, 5.54 × 10 12 vg/ml) were supplied by Shanghai Biotechnology Co., Ltd.

    Techniques: Injection, shRNA, Control, Comparison

    rAAV-CR shRNA injection caused stereotyped/repetitive behaviors, anxiety and memory impairments in naïve mice. ( A ) In the marble burying test, the number of marbles buried in animal with CR downregulation was increased than that of rAAV-EGFP-operated mice. ( B ) In the grooming test, mice with rAAV-CR shRNA injection spent more time in grooming relative to corresponding controls. ( C - D ) In the open-field test, animal with CR knockdown spent less time in the center area as compared to that of corresponding controls. No dramatical difference for the distance moved between two groups. ( E - F ) In the elevated plus maze test, the total amount of time the mouse with CR knockdown spent in the open arms was less than that of rAAV-EGFP-treated mice. No statistically apparent difference in open-arm entries was found between two groups. ( G - H ) In the novel object recognition test, rAAV-GFP-injected animals spent more time exploring the unfamiliar object as compared to the familiar one. Mice exposed with rAAV-CR injection presented significantly decreased time spent exploring the novel object in comparison with the familiar one. Animals treated with rAAV-CR shRNA exhibited decreased discrimination ratio relative to rAAV-GFP group. n = 10. *** p < 0.001, ** p < 0.01, compared with rAAV-GFP-treated mouse. ### p < 0.001 for novel object vs. familiar object. “ns” indicating no statistical significance. Student’s t -test. Data are represented as means ± SEM

    Journal: Molecular Brain

    Article Title: Deficiency of calretinin in prefrontal cortex causes behavioral deficits relevant to autism spectrum disorder in mice

    doi: 10.1186/s13041-025-01233-7

    Figure Lengend Snippet: rAAV-CR shRNA injection caused stereotyped/repetitive behaviors, anxiety and memory impairments in naïve mice. ( A ) In the marble burying test, the number of marbles buried in animal with CR downregulation was increased than that of rAAV-EGFP-operated mice. ( B ) In the grooming test, mice with rAAV-CR shRNA injection spent more time in grooming relative to corresponding controls. ( C - D ) In the open-field test, animal with CR knockdown spent less time in the center area as compared to that of corresponding controls. No dramatical difference for the distance moved between two groups. ( E - F ) In the elevated plus maze test, the total amount of time the mouse with CR knockdown spent in the open arms was less than that of rAAV-EGFP-treated mice. No statistically apparent difference in open-arm entries was found between two groups. ( G - H ) In the novel object recognition test, rAAV-GFP-injected animals spent more time exploring the unfamiliar object as compared to the familiar one. Mice exposed with rAAV-CR injection presented significantly decreased time spent exploring the novel object in comparison with the familiar one. Animals treated with rAAV-CR shRNA exhibited decreased discrimination ratio relative to rAAV-GFP group. n = 10. *** p < 0.001, ** p < 0.01, compared with rAAV-GFP-treated mouse. ### p < 0.001 for novel object vs. familiar object. “ns” indicating no statistical significance. Student’s t -test. Data are represented as means ± SEM

    Article Snippet: The recombinant adeno-associated virus (rAAV) vectors expressing CR shRNA (rAAV-GAD67-CR-shRNA-CMV-EGFP-WPRE-hGH-ITR, 5.54 × 10 12 vg/ml) were supplied by Shanghai Biotechnology Co., Ltd.

    Techniques: shRNA, Injection, Knockdown, Comparison

    In vitro whole-cell patch recordings showing the impact of CR knockdown on neuronal excitability in the PFC slices. ( A ) Fluorescent (EGFP, upper panel) and infrared differential interference contrast (DIC, bottom panel) image showing EGFP-labeled cell patched in the PFC from rAAV-EGFP and rAAV-CR shRNA mice. ( B ) Representative spiking pattern of EGFP-containing neurons traces in response to 200 pA current injection. ( C - E ) Quantitative comparisons of the resting membrane potential, action potential threshold, and rheobase current. ( F ) Evoked spike rates vs. current magnitudes in the PFC between two groups, suggesting a significant increase in mean firing frequency in rAAV-CR shRNA-treated mice compared to rAAV-EGFP group ( n = 11 cells for rAAV-GFP from 5 animals and 11 cells for rAAV-CR shRNA 5 animals). *** p < 0.001, ** p < 0.01, “ns” indicating no statistical significance; repeated measures ANOVA. Data are means ± SEM

    Journal: Molecular Brain

    Article Title: Deficiency of calretinin in prefrontal cortex causes behavioral deficits relevant to autism spectrum disorder in mice

    doi: 10.1186/s13041-025-01233-7

    Figure Lengend Snippet: In vitro whole-cell patch recordings showing the impact of CR knockdown on neuronal excitability in the PFC slices. ( A ) Fluorescent (EGFP, upper panel) and infrared differential interference contrast (DIC, bottom panel) image showing EGFP-labeled cell patched in the PFC from rAAV-EGFP and rAAV-CR shRNA mice. ( B ) Representative spiking pattern of EGFP-containing neurons traces in response to 200 pA current injection. ( C - E ) Quantitative comparisons of the resting membrane potential, action potential threshold, and rheobase current. ( F ) Evoked spike rates vs. current magnitudes in the PFC between two groups, suggesting a significant increase in mean firing frequency in rAAV-CR shRNA-treated mice compared to rAAV-EGFP group ( n = 11 cells for rAAV-GFP from 5 animals and 11 cells for rAAV-CR shRNA 5 animals). *** p < 0.001, ** p < 0.01, “ns” indicating no statistical significance; repeated measures ANOVA. Data are means ± SEM

    Article Snippet: The recombinant adeno-associated virus (rAAV) vectors expressing CR shRNA (rAAV-GAD67-CR-shRNA-CMV-EGFP-WPRE-hGH-ITR, 5.54 × 10 12 vg/ml) were supplied by Shanghai Biotechnology Co., Ltd.

    Techniques: In Vitro, Knockdown, Labeling, shRNA, Injection, Membrane

    Bio-conjugation of rAAV6 with mannose allowed high-level nanoblade-mediated knockin into CD34 + cells and reduced cell death (A and B) K562 cells were transduced at an MOI of 50,000 (vg/cell) with the unmodified rAAV2 and rAAV6 vectors (Ctrl) or with rAAV2 and rAAV6 bio-conjugated with mannose sugars at their lysine residues (K3E5 or K3E6) or tyrosine residues (Y3E5) in the presence of nanoblades. At day 3 and 6 post incubation with rAAV vectors and nanoblades, the % of knockin was determined by % of (A) GFP-expressing K562 cells and their survival using DAPI staining (B) analyzed by FACS; mean (SD); n = 3; three biological repeats; multiple Student’s t test, Tukey’s multiple comparisons test; ∗∗∗∗ p < 0.001. (C and D) CD34 + cells were pre-stimulated with cytokines overnight and were then transduced at an MOI of 50,000 (vg/cell) with the unmodified rAAV2 and rAAV6 vectors (Ctrl) or with rAAV2 and rAAV6 bio-conjugated with mannose sugars at their lysine residues (K3E5 or K3E6) or tyrosine residues (Y3E5; see also <xref ref-type=Table S1 ) in the presence of nanoblades. At day 3 and 6 post transduction, the % of GFP-positive CD34 + cells (% knockin; C) and their survival (D) were determined using FACS analysis; mean (SD); n = 3; three biological repeats for which three independent CD34 + cell donors were used; multiple Student’s t test, Tukey’s multiple comparisons test; ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001. (E) Representative FACS analysis for the data in (C) showing gene knockin by analysis of GFP expression in the CD34 + cells at day 6. " width="100%" height="100%">

    Journal: Molecular Therapy. Nucleic Acids

    Article Title: Ligand-modified rAAV6 vectors with nanoblades allow high-level gene knockin in HSPCs without compromising cell survival

    doi: 10.1016/j.omtn.2025.102495

    Figure Lengend Snippet: Bio-conjugation of rAAV6 with mannose allowed high-level nanoblade-mediated knockin into CD34 + cells and reduced cell death (A and B) K562 cells were transduced at an MOI of 50,000 (vg/cell) with the unmodified rAAV2 and rAAV6 vectors (Ctrl) or with rAAV2 and rAAV6 bio-conjugated with mannose sugars at their lysine residues (K3E5 or K3E6) or tyrosine residues (Y3E5) in the presence of nanoblades. At day 3 and 6 post incubation with rAAV vectors and nanoblades, the % of knockin was determined by % of (A) GFP-expressing K562 cells and their survival using DAPI staining (B) analyzed by FACS; mean (SD); n = 3; three biological repeats; multiple Student’s t test, Tukey’s multiple comparisons test; ∗∗∗∗ p < 0.001. (C and D) CD34 + cells were pre-stimulated with cytokines overnight and were then transduced at an MOI of 50,000 (vg/cell) with the unmodified rAAV2 and rAAV6 vectors (Ctrl) or with rAAV2 and rAAV6 bio-conjugated with mannose sugars at their lysine residues (K3E5 or K3E6) or tyrosine residues (Y3E5; see also Table S1 ) in the presence of nanoblades. At day 3 and 6 post transduction, the % of GFP-positive CD34 + cells (% knockin; C) and their survival (D) were determined using FACS analysis; mean (SD); n = 3; three biological repeats for which three independent CD34 + cell donors were used; multiple Student’s t test, Tukey’s multiple comparisons test; ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001. (E) Representative FACS analysis for the data in (C) showing gene knockin by analysis of GFP expression in the CD34 + cells at day 6.

    Article Snippet: rAAV vectors were loaded at a dose of 10 10 vg on a nitrocellulose paper soaked briefly in PBS prior to assembling the dot-blot manifold (Bio-Rad).

    Techniques: Conjugation Assay, Knock-In, Incubation, Expressing, Staining, Transduction